Medical Marketing & Media - News, Features & Insights
The latest on medical marketing. News, analysis, features, and insights for leaders, marketers, and creatives involved in promoting and commercializing prescription medicines, products, and services.
2024 MM+M Awards: All the winners
To view the digital edition of the 2024 MM+M Awards Book of the Night click here.. First, an introduction. I’m Jameson Fleming, the new editor-in-chief at MM+M.I come to this storied Haymarket publication from another legacy brand, Adweek, where I spent more than eight years learning the advertising and marketing industry inside and out.
Pipeline Report 2024: See the life-changing therapies showing …
Oct 16, 2024 · Credit: Getty Images / NEMES LASZLO/SCIENCE PHOTO LIBRARY DERMATOLOGY. Drug: JNJ-2113 / JNJ 77242113. Company: Johnson & Johnson Indication: Psoriasis Stage: Phase III Sales estimate: $292 million by 2029 — Global Data Background: JNJ-2113 is a novel oral IL-23R antagonist peptide that binds with high affinity to the IL-23R and has properties that allow it to be absorbed with oral dosing.
Rare Disease Agency of the Year 2024 - MM+M Awards
Gold. Havas Life Rare. Havas Life Rare, formerly H4B Boston, wins gold again this year for its outstanding work as a commercialization and marketing partner for orphan drugs and rare disease markets.
Post-election prescription: Why Trump’s return could disrupt pharma
Nov 8, 2024 · The world has changed in the past five years in how we market to HCPs and patients, payers and policymakers. Meantime, various stakeholders are falling behind in supporting various engagements and it’s not serving anyone well.
2023 MM+M Awards: All the Winners
The MM+M Awards is celebrating its 20th year of recognizing healthcare marketing and media that is the most creative and effective in the industry.
MM+M unveils its 2024 Awards shortlist
Jul 11, 2024 · MM+M today revealed its 2024 MM+M Awards finalists. Now in its 21st year, the medical marketing industry’s premier awards program recognizes the campaigns, organizations and people who created the year’s most compelling — and impactful — work.
Agency 100 2024: VML Health - MM+M
Jun 11, 2024 · The call came straight from the top — Jon Cook, global CEO of VML — and it delivered a message that both shocked and energized the world of medical marketing agencies: Two of its biggest and best-regarded firms, VMLY&R Health and Wunderman Thompson Health, were about to become one.
Large Healthcare Agency of the Year 2024 - MM+M Awards
Silver. The Weber Shandwick Collective. Committed to delivering impactful, innovative solutions that help clients navigate an ever-evolving healthcare landscape, this agency stands out for its global footprint, use of AI and truly astonishing public relations prowess.
Five things for pharma marketers to know for Wednesday morning
Dec 18, 2024 · Namandje Bumpus, deputy commissioner of the Food and Drug Administration, said she will leave the agency at the end of the year. She is the second high level official set to leave the FDA after the election of President-elect Donald Trump. (Endpoints News) Truth-teller or reflexive contrarian: Which ...
- Some results have been removed